M. Kulyk & Associates’s Cigna CI Stock Holding History

M. Kulyk & Associates’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-704	Closed	-$203K	–	109
2025 Q3	$203K	Hold	704	–	–	0.04%	104
2025 Q2	$233K	Hold	704	–	–	0.05%	96
2025 Q1	$231K	Buy	+704	New	+$212K	0.05%	91
2024 Q4	–	Sell	-699	Closed	-$242K	–	108
2024 Q3	$242K	Hold	699	–	–	0.05%	101
2024 Q2	$231K	Hold	699	–	–	0.05%	101
2024 Q1	$254K	Hold	699	–	–	0.06%	97
2023 Q4	$209K	Hold	699	–	–	0.05%	105
2023 Q3	$200K	Sell	699 -67	-9%	-$19.1K	0.06%	94
2023 Q2	$215K	Buy	+766	New	+$199K	0.06%	105
2023 Q1	–	Sell	-753	Closed	-$249K	–	107
2022 Q4	$249K	Sell	753 -20	-3%	-$6.33K	0.08%	90
2022 Q3	$214K	Buy	+773	New	+$218K	0.07%	95

Other funds holding CI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

M. Kulyk & Associates's CI Position: Q4 2025 in Review

M. Kulyk & Associates sold out of Cigna (CI) in Q4 2025, closing a stake of 704 shares — an estimated $203K sold.

M. Kulyk & Associates first reported a position in CI in Q3 2022 and held it in 11 quarters. The position peaked at $254K in Q1 2024. 1,656 funds tracked by Wall St. Rank hold CI as of Q4 2025.

M. Kulyk & Associates reported no remaining Cigna position as of Q4 2025 after selling out during the quarter.
M. Kulyk & Associates sold 704 Cigna shares in Q4 2025, an estimated $203K.
M. Kulyk & Associates first reported a position in Cigna in Q3 2022 and held it in 11 quarters.
M. Kulyk & Associates's Cigna position peaked at $254K in Q1 2024.
1,656 funds tracked by Wall St. Rank held Cigna as of Q4 2025.

Based on M. Kulyk & Associates's 13F filing for Q4 2025, filed 8 Jan 2026.